Quarterly ResultApr 28, 2026, 04:12 PM
NRC Health Q1 Revenue +4% to $34.8M; TRCV +13% to $152.1M
AI Summary
NRC Health announced strong first quarter 2026 results, with total revenue increasing 4% year-over-year to $34.8 million, marking its first quarter of year-over-year revenue growth since 2023. Total Recurring Contract Value (TRCV) grew 13% to $152.1 million, and net cash flow from operating activities rose 8% to $7.2 million. The company also reported signing the largest deal in its 45-year history and declared a quarterly cash dividend of $0.16 per share.
Key Highlights
- Total Recurring Contract Value (TRCV) increased 13% year-over-year to $152.1 million.
- Total revenue grew 4% year-over-year to $34.8 million.
- GAAP net income was $3.2 million, with diluted EPS of $0.14.
- Adjusted EBITDA reached $9.4 million, representing 27% of revenue.
- Net cash flow from operating activities increased 8% year-over-year to $7.2 million.
- The Board of Directors declared a quarterly cash dividend of $0.16 per share.
- Company signed the largest deal in its 45-year history.
- New sales and customer retention reached multi-year highs this quarter.